Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: An appraisal

Archives of Gynecology and Obstetrics

Volumn 273, Issue 6, 2006, Pages 322-324

  Wiwanitkit, Viroj ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Plasminogen activator inhibitor 1; Polymorphism; Pre eclampsia

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; PREECLAMPSIA; PREGNANCY COMPLICATION; RISK ASSESSMENT;

CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HUMANS; ODDS RATIO; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY;

EID: 33644529728     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-005-0117-8     Document Type: Article

References (14)

1. Francis CW (2002) Plasminogen activator inhibitor-1 levels and polymorphisms. Arch Pathol Lab Med 126:1401-1404
2. Banfi C, Mussoni L, Tremoli E (2002) PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms. Minerva Endocrinol 27:181-191
3. Nordt TK, Lohrmann J, Bode C (2001) Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis. Thromb Res 103(Suppl 1):S1-S5
4. Said J, Dekker G (2003) Pre-eclampsia and thrombophilia. Best Pract Res Clin Obstet Gynaecol 17:441-458
5. Hakli T, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S (2003) Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia. Genet Test 7:265-268
6. Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, Kubo T, Hamaguchi H (2000) The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet 45:138-141
7. Pegoraro RJ, Hira B, Rom L, Moodley J (2003) Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with preeclampsia. Acta Obstet Gynecol Scand 82:313-317
8. Tempfer CB, Jirecek S, Riener EK, Zeisler H, Denschlag D, Hefler L, Husslein PW (2004) Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig 11:227-231
9. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA (2002) Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 87:779-785
10. Fabbro D, D'Elia AV, Spizzo R, Driul L, Barillari G, Di Loreto C, Marchesoni D, Damante G (2003) Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest 56:17-22
11. Wiman B, Csemiczky G, Marsk L, Robbe H (1984) The fast inhibitor of tissue plasminogen activator in plasma during pregnancy. Thromb Haemost 52:124-126
12. de Boer K, Lecander I, ten Cate JW, Borm JJ, Treffers PE (1988) Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 158:518-522
13. Gore M, Eldon S, Trofatter KF, Soong SJ, Pizzo SV (1987) Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor. Am J Obstet Gynecol 156:674-680
14. Glueck CJ, Kupfermine MJ, Fontaine RN, Wang P, Weksler BB, Eldor A (2001) Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 97:44-48